{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:32:52Z","timestamp":1778509972017,"version":"3.51.4"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX005794, 1IK6BX004607"],"award-info":[{"award-number":["I01BX005794, 1IK6BX004607"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI139290, AI123449, AI1498033, 75N93019C00051, HHSN272201400008C, HHSN272201400006C, AI141990, AI150747, AI140909"],"award-info":[{"award-number":["AI139290, AI123449, AI1498033, 75N93019C00051, HHSN272201400008C, HHSN272201400006C, AI141990, AI150747, AI140909"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Antibodies against the SARS-CoV-2 spike protein are a critical immune determinant for protection against the virus. While virus neutralization is a key function of spike-specific antibodies, antibodies also mediate Fc-dependent activities that can play a role in protection or pathogenesis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study characterized serum antibody responses elicited after two doses of heterologous adenovirus-vectored (Ad26\/ Ad5) vaccines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Vaccine-induced antibody binding titers and Fc-mediated functions decreased over six months, while neutralization titers remained stable. Comparison of antibody isotypes elicited after Ad26\/Ad5 vs. LNP-mRNA vaccination and after infection showed that anti-spike IgG1 were dominant and produced to high levels in all groups. The Ad26\/Ad5 vaccines also induced IgG4 but not IgG2 and IgG3, whereas the LNP-mRNA vaccines elicited a full Ig spectrum (IgM, IgG1-4, IgA1-2). Convalescent COVID-19 patients had mainly IgM and IgA1 alongside IgG1. Despite these differences, the neutralization potencies against early variants were similar. However, both vaccine groups had antibodies with greater Fc potencies of binding complement and Fcg receptors than the COVID-19 group. The Ad26\/Ad5 group also displayed a greater potency of RBD-specific antibody-mediated cellular phagocytosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Antibodies with distinctive quality were induced by different vaccines and infection. The data imply the utility of different vaccine platforms to elicit antibody responses with fine-tuned Fc activities.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1382619","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:38:29Z","timestamp":1715143109000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Heterologous Ad26\/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities"],"prefix":"10.3389","volume":"15","author":[{"given":"J\u00e9romine","family":"Klingler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreyas","family":"Kowdle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Bandres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozita","family":"Emami-Gorizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond A.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka G.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Amanat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Gleason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Perandones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benhur","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina E.","family":"Hioe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40199-022-00446-8","article-title":"A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines","volume":"30","author":"Abdolmaleki","year":"2022","journal-title":"Daru J Fac Pharm Tehran Univ Med Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00281-21","article-title":"COVID-19 severity is associated with differential antibody fc-mediated innate immune functions","volume":"12","author":"Adeniji","year":"2021","journal-title":"mBio"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-01813-2","article-title":"Mounting evidence suggests Sputnik COVID vaccine is safe and effective","volume":"595","author":"Nogrady","year":"2021","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00191-4","article-title":"Sputnik V COVID-19 vaccine candidate appears safe and effective","volume":"397","author":"Jones","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"B6","article-title":"Active monitoring of early safety of Sputnik V vaccine in Buenos Aires, Argentina","volume":"81","author":"Pagotto","year":"2021","journal-title":"Medicina (Mex)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/v13112114","article-title":"Mutational hotspot in the SARS-coV-2 spike protein N-terminal domain conferring immune escape potential","volume":"13","author":"Kubik","year":"2021","journal-title":"Viruses"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.06.026","article-title":"The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac","volume":"28","author":"Tonnara","year":"2022","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-coV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9070779","article-title":"Neutralizing activity of sera from sputnik V-vaccinated people against variants of concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and moscow endemic SARS-coV-2 variants","volume":"9","author":"Gushchin","year":"2021","journal-title":"Vaccines"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109415","article-title":"SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination","volume":"36","author":"Hoffmann","year":"2021","journal-title":"Cell Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","article-title":"SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies","volume":"184","author":"Hoffmann","year":"2021","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.992370","article-title":"Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina","volume":"13","author":"Rodriguez","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113220","article-title":"Microarray profiling of vaccination-induced antibody responses to SARS-coV-2 variants of interest and concern","volume":"23","author":"Svetlova","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100123","article-title":"Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucum\u00e1n, Argentina","volume":"6","author":"Chahla","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4598","DOI":"10.1038\/s41467-021-24909-9","article-title":"Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants","volume":"12","author":"Ikegame","year":"2021","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04388-0","article-title":"Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"NEJMoa2119451","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"NEJMoa2203209","DOI":"10.1056\/NEJMoa2203209","article-title":"Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age","volume":"387","author":"Tan","year":"2022","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm2311","article-title":"mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions","volume":"14","author":"Kaplonek","year":"2022","journal-title":"Sci Transl Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00813-1","article-title":"Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection","volume":"23","author":"Zhang","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10060938","article-title":"Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance","volume":"10","author":"Shkoda","year":"2022","journal-title":"Vaccines"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/v15061349","article-title":"Functional Characteristics of Serum Anti-SARS-CoV-2 Antibodies against Delta and Omicron Variants after Vaccination with Sputnik V","volume":"15","author":"Radion","year":"2023","journal-title":"Viruses"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01837-22","article-title":"Serum fc-mediated monocyte phagocytosis activity is stable for several months after SARS-CoV-2 asymptomatic and mildly symptomatic infection","volume":"10","author":"Vangeti","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.759688","article-title":"Detection of antibody responses against SARS-CoV-2 in plasma and saliva from vaccinated and infected individuals","volume":"12","author":"Klingler","year":"2021","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03696-9","article-title":"Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105608","article-title":"Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients","volume":"25","author":"Klingler","year":"2022","journal-title":"iScience"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa784","article-title":"Role of immunoglobulin M and A antibodies in the neutralization of severe acute respiratory syndrome coronavirus 2","volume":"223","author":"Klingler","year":"2021","journal-title":"J Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.immuni.2021.07.008","article-title":"Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations","volume":"54","author":"Muecksch","year":"2021","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101048","article-title":"Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines","volume":"4","author":"Kaplonek","year":"2023","journal-title":"Cell Rep Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1038\/s41467-023-39189-8","article-title":"Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination","volume":"14","author":"Tong","year":"2023","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.immuni.2022.01.001","article-title":"mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern","volume":"55","author":"Kaplonek","year":"2022","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00254","article-title":"Contribution of human fc\u03b3Rs to disease with evidence from human polymorphisms and transgenic animal studies","volume":"5","author":"Gillis","year":"2014","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.166.5.1351","article-title":"Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies","volume":"166","author":"Br\u00fcggemann","year":"1987","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830210103","article-title":"Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration","volume":"21","author":"Michaelsen","year":"1991","journal-title":"Eur J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2012.03.021","article-title":"Isotype and glycoform selection for antibody therapeutics","volume":"526","author":"Jefferis","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1021\/bp050228w","article-title":"Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vivo","volume":"21","author":"Hodoniczky","year":"2005","journal-title":"Biotechnol Prog"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(95)00118-2","article-title":"The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H","volume":"32","author":"Boyd","year":"1995","journal-title":"Mol Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1702173114","article-title":"Modulating IgG effector function by Fc glycan engineering","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1307864110","article-title":"General mechanism for modulating immunoglobulin effector function","volume":"110","author":"Sondermann","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.immuni.2020.07.020","article-title":"Distinct early serological signatures track with SARS-coV-2 survival","volume":"53","author":"Atyeo","year":"2020","journal-title":"Immunity"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab3886","article-title":"Protective efficacy of adenovirus\/protein vaccines against SIV challenges in rhesus monkeys","volume":"349","author":"Barouch","year":"2015","journal-title":"Science"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG Fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/1462-2920.15549","article-title":"COVID-19: vaccination problems","volume":"23","author":"Br\u00fcssow","year":"2021","journal-title":"Environ Microbiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100313","article-title":"Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions","volume":"2","author":"Shiakolas","year":"2021","journal-title":"Cell Rep Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"Amanat","year":"2020","journal-title":"Nat Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 seroconversion in humans: A detailed protocol for a serological assay, antigen production, and test setup","volume":"57","author":"Stadlbauer","year":"2020","journal-title":"Curr Protoc Microbiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110904","article-title":"IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes","volume":"39","author":"Garrido","year":"2022","journal-title":"Cell Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1382619\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:38:33Z","timestamp":1715143113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1382619\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2024.1382619"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1382619","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"article-number":"1382619"}}